Are the Pieces Starting to Come Together for Management of Desmoid Tumors?
- PMID: 35819317
- DOI: 10.1158/1078-0432.CCR-22-0620
Are the Pieces Starting to Come Together for Management of Desmoid Tumors?
Abstract
Desmoid tumor research is changing how desmoid tumors are managed with the prospective documentation that growing desmoid tumors spontaneously regress one third of the time. Patient partnership through the Desmoid Research Tumor Foundation and academia is leading to rapid advancement in desmoid tumor biology understanding and treatment. See related articles by Colombo et al., p. 4027, Nathenson et al., p. 4092, and Penel et al., p. 4105.
©2022 American Association for Cancer Research.
Comment on
-
Systemic Chemotherapies Retain Antitumor Activity in Desmoid Tumors Independent of Specific Mutations in CTNNB1 or APC: A Multi-institutional Retrospective Study.Clin Cancer Res. 2022 Sep 15;28(18):4092-4104. doi: 10.1158/1078-0432.CCR-21-4504. Clin Cancer Res. 2022. PMID: 35180772 Free PMC article.
-
A Prospective Observational Study of Active Surveillance in Primary Desmoid Fibromatosis.Clin Cancer Res. 2022 Sep 15;28(18):4027-4032. doi: 10.1158/1078-0432.CCR-21-4205. Clin Cancer Res. 2022. PMID: 35247923
-
Lack of Prognostic Value of CTNNB1 Mutation Profile in Desmoid-Type Fibromatosis.Clin Cancer Res. 2022 Sep 15;28(18):4105-4111. doi: 10.1158/1078-0432.CCR-21-4235. Clin Cancer Res. 2022. PMID: 35294527
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous
